Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Queen's University CIHR |
---|---|
Information provided by: | Queen's University |
ClinicalTrials.gov Identifier: | NCT00542347 |
Proton pump inhibitors (PPI) are used to decrease stomach acid secretion. A generic form of omeprazole, one of the PPIs, is on the market. With cheaper than brand name PPIs, it is unclear whether generic omeprazole is as effective clinically. This study compares generic omeprazole with half-dose esomeprazole, the strongest brand name PPI. The half-dose esomeprazole is in fact cheaper than generic omeprazole. Healthy volunteers will take each medication in turn for 7 days and their stomach acid will be measured while taking each medication. We hypothesize that half-dose esomeprazole is better at suppressing stomach acid than generic omeprazole.
Condition | Intervention | Phase |
---|---|---|
Gastric Acid |
Drug: Esomeprazole first Drug: Generic omeprazole first |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Dose Comparison, Crossover Assignment, Efficacy Study |
Official Title: | Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole |
Estimated Enrollment: | 20 |
Study Start Date: | September 2007 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
|
Drug: Esomeprazole first
|
2: Active Comparator
|
Drug: Generic omeprazole first
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jackie MacKay | (613)544-3400 ext 2440 | mckayj@hdh.kari.net |
Canada, Ontario | |
Hotel Dieu Hospital | Recruiting |
Kingston, Ontario, Canada, K7L 5G2 |
Principal Investigator: | William G Paterson, MD | Queen's University, Hotel Dieu Hospital |
Principal Investigator: | Adriana Lazarescu, MD | Hotel Dieu Hospital |
Responsible Party: | Division of Gastroenterology, Queen's University ( Dr. W.G. Paterson MD ) |
Study ID Numbers: | 1054-07 |
Study First Received: | October 9, 2007 |
Last Updated: | December 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00542347 |
Health Authority: | Canada: Ethics Review Committee |
gastric acid proton pump inhibitors omeprazole esomeprazole |
Omeprazole |
Molecular Mechanisms of Pharmacological Action Therapeutic Uses Anti-Ulcer Agents |
Gastrointestinal Agents Enzyme Inhibitors Pharmacologic Actions |